The test has a sensitivity of 96.52% and specificity of 99.68%. Credit: David Talukdar/Getty Images

Medical technology services provider Althea UK and Ireland has launched high-quality and cost-effective SARS-CoV-2 rapid antigen tests.

Manufactured by Roche, the antibody test can help identify SARS-CoV-2 infection in suspected people and can deliver results in 15 minutes.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It is a rapid chromatographic immunoassay, which uses nasopharyngeal swab samples for testing and has a sensitivity of 96.52% and specificity of 99.68%.

In addition, the test can be used for symptomatic and asymptomatic individuals.

The company noted that the latest service, which is accessible for pharmacies, dentists, hospitals, clinics, and hospital support companies whose staff access clinical settings, will offer a valuable initial screening test for staff who are possibly exposed to Covid-19 or work in high-risk settings.

Althea CEO David Rolfe said: “As Covid-19 continues to spread and while vaccinations are being rolled out, testing remains crucial to contain the spread of Covid-19.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are pleased to be able to offer the Roche rapid antigen tests to support those providing vital services across the country with a reliable, high-quality testing option at an affordable price.

“At a time where budgets are stretched and health services are under pressure, as a trusted partner to many hospitals in the UK, we want to do our part in supporting those working on the frontline.”

The company manages and maintains medical technology in hospitals and is entirely vendor-independent, meaning they can combine the best technology from across all manufacturers.

Althea noted that during Covid-19, it performed a major role in setting up equipment at the London NHS Nightingale Hospital, which was established to provide emergency care to Covid-19 patients.

Currently, the company offers rapid Covid-19 tests to help further support the national response to the pandemic.